应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ORGO Organogenesis Holdings Inc
交易中 03-02 12:11:43 EST
2.98
-0.23
-7.17%
最高
3.17
最低
2.91
成交量
41.67万
今开
3.05
昨收
3.21
日振幅
8.10%
总市值
3.83亿
流通市值
1.73亿
总股本
1.29亿
成交额
125.23万
换手率
0.72%
流通股本
5,795万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Organogenesis Holdings Inc.盘中异动 股价大涨5.12%
市场透视 · 2025-12-18
Organogenesis Holdings Inc.盘中异动 股价大涨5.12%
Organogenesis宣布成功召开FDA会议并计划提交Renu®的生物制剂申请以治疗膝关节骨关节炎疼痛
美股速递 · 2025-12-16
Organogenesis宣布成功召开FDA会议并计划提交Renu®的生物制剂申请以治疗膝关节骨关节炎疼痛
Organogenesis Holdings Inc.2024财年实现净利润861000.00美元,同比减少82.61%
市场透视 · 2025-03-08
Organogenesis Holdings Inc.2024财年实现净利润861000.00美元,同比减少82.61%
异动解读 | 大摩上调Organogenesis Holdings目标价致其股价大涨5.16%
异动解读 · 2025-03-05
异动解读 | 大摩上调Organogenesis Holdings目标价致其股价大涨5.16%
Organogenesis Holdings Inc.盘中异动 早盘股价大涨5.16%报5.30美元
市场透视 · 2025-03-05
Organogenesis Holdings Inc.盘中异动 早盘股价大涨5.16%报5.30美元
大摩:维持Organogenesis Holdings(ORGO.US)评级,由持股观望调整至持股观望评级, 目标价由4.00美元调整至6.00美元。
金融界 · 2025-03-05
大摩:维持Organogenesis Holdings(ORGO.US)评级,由持股观望调整至持股观望评级, 目标价由4.00美元调整至6.00美元。
Organogenesis Holdings Inc.盘中异动 早盘股价大跌5.18%
市场透视 · 2025-03-04
Organogenesis Holdings Inc.盘中异动 早盘股价大跌5.18%
Organogenesis Holdings Inc.盘中异动 早盘股价大涨5.11%
市场透视 · 2025-03-03
Organogenesis Holdings Inc.盘中异动 早盘股价大涨5.11%
Organogenesis Holdings Inc.盘中异动 急速拉升30.94%
市场透视 · 2025-02-28
Organogenesis Holdings Inc.盘中异动 急速拉升30.94%
Organogenesis Hldgs 第四季度调整后每股收益 $0.07 超出 $(0.01) 的预期,销售额 $1.2666 亿超出 $1.0960 亿的预期
财报速递 · 2025-02-28
Organogenesis Hldgs 第四季度调整后每股收益 $0.07 超出 $(0.01) 的预期,销售额 $1.2666 亿超出 $1.0960 亿的预期
Organogenesis Holdings Inc.盘中异动 急速跳水5.54%
市场透视 · 2025-02-28
Organogenesis Holdings Inc.盘中异动 急速跳水5.54%
Organogenesis Holdings Inc.盘中异动 早盘股价大跌5.16%
市场透视 · 2025-02-03
Organogenesis Holdings Inc.盘中异动 早盘股价大跌5.16%
Organogenesis Holdings Inc.盘中异动 下午盘急速下挫5.08%
市场透视 · 2025-01-29
Organogenesis Holdings Inc.盘中异动 下午盘急速下挫5.08%
Organogenesis Holdings Inc.盘中异动 快速拉升5.06%
市场透视 · 2025-01-27
Organogenesis Holdings Inc.盘中异动 快速拉升5.06%
Organogenesis Holdings Inc.盘中异动 股价大涨5.39%报3.52美元
市场透视 · 2025-01-22
Organogenesis Holdings Inc.盘中异动 股价大涨5.39%报3.52美元
Organogenesis Holdings Inc.盘中异动 早盘急速跳水5.11%
市场透视 · 2025-01-10
Organogenesis Holdings Inc.盘中异动 早盘急速跳水5.11%
Organogenesis Holdings Inc.盘中异动 下午盘股价大跌5.00%
市场透视 · 2025-01-03
Organogenesis Holdings Inc.盘中异动 下午盘股价大跌5.00%
Organogenesis Holdings Inc.盘中异动 大幅下跌5.03%
市场透视 · 2024-12-28
Organogenesis Holdings Inc.盘中异动 大幅下跌5.03%
Organogenesis Holdings Inc.盘中异动 股价大涨5.08%报3.21美元
市场透视 · 2024-12-24
Organogenesis Holdings Inc.盘中异动 股价大涨5.08%报3.21美元
Organogenesis Holdings Inc.盘中异动 股价大跌5.04%
市场透视 · 2024-12-19
Organogenesis Holdings Inc.盘中异动 股价大跌5.04%
加载更多
公司概况
公司名称:
Organogenesis Holdings Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Organogenesis Holdings Inc.是特拉华州的一家公司。该公司是一家领先的再生医学公司,在先进的伤口护理和外科生物制剂(包括骨科和脊柱)中提供生物活性和非细胞生物材料产品组合。Organogenesis全面的产品组合旨在治疗各种有修复和再生需求的患者。
发行价格:
--
{"stockData":{"symbol":"ORGO","market":"US","secType":"STK","nameCN":"Organogenesis Holdings Inc","latestPrice":2.98,"timestamp":1772471502462,"preClose":3.21,"halted":0,"volume":416716,"delay":0,"changeRate":-0.07165109034267912,"floatShares":57945200,"shares":128640671,"eps":0.15,"marketStatus":"交易中","change":-0.23,"latestTime":"03-02 12:11:43 EST","open":3.05,"high":3.165,"low":2.905,"amount":1252255.4578268,"amplitude":0.080997,"askPrice":2.98,"askSize":645,"bidPrice":2.97,"bidSize":621,"shortable":0,"etf":0,"ttmEps":0.15,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772485200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.21,"preHourTrading":{"tag":"盘前","latestPrice":3.1,"preClose":3.21,"latestTime":"09:29 EST","volume":5862,"amount":18806.3916078,"timestamp":1772461799907,"change":-0.11,"changeRate":-0.034268,"amplitude":0.096573},"postHourTrading":{"tag":"盘后","latestPrice":3.2054,"preClose":3.21,"latestTime":"18:49 EST","volume":12003,"amount":38469.5279,"timestamp":1772236178367,"change":-0.0046,"changeRate":-0.001433,"amplitude":0.003115},"volumeRatio":1.251337,"impliedVol":2.1435,"impliedVolPercentile":0.7968},"requestUrl":"/m/hq/s/ORGO","defaultTab":"news","newsList":[{"id":"2592790725","title":"Organogenesis Holdings Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592790725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592790725?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:33","pubTimestamp":1766068385,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日22时33分,Organogenesis Holdings Inc.股票出现波动,股价急速上涨5.12%。Organogenesis Holdings Inc.股票所在的制药行业中,整体涨幅为1.08%。其相关个股中,Akanda Corp.、Canopy Growth Corporation、Tilray Brands, Inc.涨幅较大,Akanda Corp.、Cbdmd, Inc.、Inmed Pharmaceuticals Inc.较为活跃,换手率分别为421.56%、70.65%、4.28%,振幅较大的相关个股有Biofrontera Inc.、Akanda Corp.、Cbdmd, Inc.,振幅分别为13.89%、10.35%、8.15%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场产品解决方案的开发、制造和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121822330697a0760d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121822330697a0760d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"gpt_icon":0},{"id":"1101439563","title":"Organogenesis宣布成功召开FDA会议并计划提交Renu®的生物制剂申请以治疗膝关节骨关节炎疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1101439563","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101439563?lang=zh_cn&edition=full","pubTime":"2025-12-16 05:25","pubTimestamp":1765833911,"startTime":"0","endTime":"0","summary":"Organogenesis宣布成功召开FDA会议并计划提交Renu®的生物制剂申请以治疗膝关节骨关节炎疼痛","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORGO","BK4139"],"gpt_icon":0},{"id":"2517453907","title":"Organogenesis Holdings Inc.2024财年实现净利润861000.00美元,同比减少82.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517453907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517453907?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363255,"startTime":"0","endTime":"0","summary":"3月8日,Organogenesis Holdings Inc.公布财报,公告显示公司2024财年净利润为861000.00美元,同比减少82.61%;其中营业收入为4.82亿美元,同比增加11.32%,每股基本收益为0.01美元。机构评级:截至2025年3月8日,当前有4家机构对Organogenesis Holdings Inc.目标价做出预测,其中目标均价为6.00美元,其中最低目标价为5.00美元,最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000245abed66e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000245abed66e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO"],"gpt_icon":0},{"id":"1128515965","title":"异动解读 | 大摩上调Organogenesis Holdings目标价致其股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128515965","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128515965?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:33","pubTimestamp":1741185225,"startTime":"0","endTime":"0","summary":"Organogenesis Holdings Inc(股票代码:ORGO)今日盘中股价大涨5.16%,引起了市场的广泛关注。\n\n从消息面上看,大摩证券分析师刚刚调高了对ORGO的目标股价,由之前的4.00美元上调至6.00美元。此外,大摩维持了对ORGO的\"持股观望\"评级。这表明分析师对ORGO的长期前景持乐观态度,投资者受此利好消息影响,推高了ORGO股价。\n\n总的来说,分析师上调目标股价,提振了投资者对ORGO未来发展前景的信心,导致了今日ORGO股价的大涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 大摩上调Organogenesis Holdings目标价致其股价大涨5.16%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ORGO"],"gpt_icon":0},{"id":"2517316948","title":"Organogenesis Holdings Inc.盘中异动 早盘股价大涨5.16%报5.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517316948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517316948?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185107,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分,Organogenesis Holdings Inc.股票出现异动,股价大幅上涨5.16%。截至发稿,该股报5.30美元/股,成交量5.7391万股,换手率0.05%,振幅1.70%。Organogenesis Holdings Inc.股票所在的制药行业中,整体跌幅为0.20%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223147963adc5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223147963adc5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"gpt_icon":0},{"id":"2517917991","title":"大摩:维持Organogenesis Holdings(ORGO.US)评级,由持股观望调整至持股观望评级, 目标价由4.00美元调整至6.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517917991","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517917991?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:14","pubTimestamp":1741184061,"startTime":"0","endTime":"0","summary":"大摩:维持Organogenesis Holdings(ORGO.US)评级,由持股观望调整至持股观望评级, 目标价由4.00美元调整至6.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05221448547688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ORGO"],"gpt_icon":0},{"id":"2516791670","title":"Organogenesis Holdings Inc.盘中异动 早盘股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516791670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516791670?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:31","pubTimestamp":1741098697,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时31分,Organogenesis Holdings Inc.股票出现波动,股价快速跳水5.18%。截至发稿,该股报5.13美元/股,成交量4.5083万股,换手率0.04%,振幅0.83%。Organogenesis Holdings Inc.股票所在的制药行业中,整体涨幅为0.04%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223137abe7ef52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223137abe7ef52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"gpt_icon":0},{"id":"2516863403","title":"Organogenesis Holdings Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516863403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516863403?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:41","pubTimestamp":1741012892,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时41分,Organogenesis Holdings Inc.股票出现波动,股价急速上涨5.11%。Organogenesis Holdings Inc.股票所在的制药行业中,整体涨幅为0.35%。其相关个股中,Sunshine Biopharma Inc C/Wts 、Scilex Holding Company、Intercure Ltd.涨幅较大,苏轩堂、Petros Pharmaceuticals, Inc.、大自然药业较为活跃,换手率分别为6.33%、3.47%、3.04%,振幅较大的相关个股有Organogenesis Holdings Inc.、Redhill Biopharma Ltd、Scilex Holding Company,振幅分别为9.02%、7.50%、6.36%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224133abe6368a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224133abe6368a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"gpt_icon":0},{"id":"2514889378","title":"Organogenesis Holdings Inc.盘中异动 急速拉升30.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514889378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514889378?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753071,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分,Organogenesis Holdings Inc.股票出现波动,股价快速拉升30.94%。Organogenesis Holdings Inc.股票所在的制药行业中,整体涨幅为0.01%。其相关个股中,Organogenesis Holdings Inc.、百利高、Ani Pharmaceuticals, Inc.涨幅较大,Petros Pharmaceuticals, Inc.、大自然药业、Quantum Biopharma Ltd.较为活跃,换手率分别为1.97%、1.39%、0.63%,振幅较大的相关个股有Kamada Ltd.、Esperion Therapeutics, Inc.、Organogenesis Holdings Inc.,振幅分别为3.62%、1.66%、1.57%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223111abe0ea07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223111abe0ea07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"gpt_icon":0},{"id":"1196357298","title":"Organogenesis Hldgs 第四季度调整后每股收益 $0.07 超出 $(0.01) 的预期,销售额 $1.2666 亿超出 $1.0960 亿的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1196357298","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196357298?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:31","pubTimestamp":1740691919,"startTime":"0","endTime":"0","summary":"公司报告季度销售额为 $1.2666 亿,超出分析师一致预期的 $1.0960 亿,增长了 15.56%。以上内容来自Benzinga Earnings专栏,原文如下:Organogenesis Hldgs reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $ by 800 percent. This is a 600 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $126.66 million which beat the analyst consensus estimate of $109.60 million by 15.56 percent. This is a 27.10 percent increase over sales of $99.6","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Organogenesis Hldgs 第四季度调整后每股收益 $0.07 超出 $(0.01) 的预期,销售额 $1.2666 亿超出 $1.0960 亿的预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORGO"],"gpt_icon":0},{"id":"2514833053","title":"Organogenesis Holdings Inc.盘中异动 急速跳水5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514833053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514833053?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:01","pubTimestamp":1740690119,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日05时01分,Organogenesis Holdings Inc.股票出现异动,股价快速下挫5.54%。截至发稿,该股报3.07美元/股,成交量38.6882万股,换手率0.31%,振幅6.46%。Organogenesis Holdings Inc.股票所在的制药行业中,整体跌幅为0.47%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228050200989556c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228050200989556c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"gpt_icon":0},{"id":"2508317144","title":"Organogenesis Holdings Inc.盘中异动 早盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508317144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508317144?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:53","pubTimestamp":1738594417,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时53分,Organogenesis Holdings Inc.股票出现异动,股价快速下跌5.16%。截至发稿,该股报3.49美元/股,成交量4.2559万股,换手率0.03%,振幅2.45%。Organogenesis Holdings Inc.股票所在的制药行业中,整体跌幅为0.09%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225337987972e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225337987972e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"gpt_icon":0},{"id":"2507354467","title":"Organogenesis Holdings Inc.盘中异动 下午盘急速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507354467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507354467?lang=zh_cn&edition=full","pubTime":"2025-01-29 02:10","pubTimestamp":1738087839,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日02时10分,Organogenesis Holdings Inc.股票出现异动,股价大幅下挫5.08%。Organogenesis Holdings Inc.股票所在的制药行业中,整体跌幅为0.28%。其相关个股中,Cbdmd, Inc.、Eton Pharmaceuticals, Inc.、Aquestive Therapeutics, Inc.涨幅较大,Cbdmd, Inc.、Painreform Ltd.、Inmed Pharmaceuticals Inc.较为活跃,换手率分别为252.00%、24.20%、6.41%,振幅较大的相关个股有Cbdmd, Inc.、Painreform Ltd.、Shuttle Pharmaceuticals Holdings, Inc.,振幅分别为48.61%、13.35%、12.94%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129021039abbb9159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129021039abbb9159&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"gpt_icon":0},{"id":"2506305285","title":"Organogenesis Holdings Inc.盘中异动 快速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506305285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506305285?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:38","pubTimestamp":1737988723,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时38分,Organogenesis Holdings Inc.股票出现波动,股价大幅上涨5.06%。Organogenesis Holdings Inc.股票所在的制药行业中,整体涨幅为0.87%。其相关个股中,Alpha Teknova, Inc.、Sunshine Biopharma Inc C/Wts 、Scilex Holding Company涨幅较大,Painreform Ltd.、大自然药业、苏轩堂较为活跃,换手率分别为25.63%、5.79%、5.61%,振幅较大的相关个股有Alpha Teknova, Inc.、Petros Pharmaceuticals, Inc.、Scilex Holding Company,振幅分别为9.02%、7.90%、6.79%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223844a2316c90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223844a2316c90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"gpt_icon":0},{"id":"2505202496","title":"Organogenesis Holdings Inc.盘中异动 股价大涨5.39%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505202496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505202496?lang=zh_cn&edition=full","pubTime":"2025-01-22 02:06","pubTimestamp":1737482813,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日02时06分,Organogenesis Holdings Inc.股票出现异动,股价急速上涨5.39%。截至发稿,该股报3.52美元/股,成交量8.0796万股,换手率0.06%,振幅4.49%。Organogenesis Holdings Inc.股票所在的制药行业中,整体涨幅为1.44%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。其部分产品包括 PuraPly Antimicrobial、Affinity、NuShield、Apligraf、Dermagraft 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020653986e58f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020653986e58f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"gpt_icon":0},{"id":"2502983598","title":"Organogenesis Holdings Inc.盘中异动 早盘急速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502983598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502983598?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:05","pubTimestamp":1736521538,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时05分,Organogenesis Holdings Inc.股票出现波动,股价大幅下挫5.11%。Organogenesis Holdings Inc.股票所在的制药行业中,整体涨幅为0.33%。其相关个股中,Intra-Cellular Therapies Inc.、Pacira Biosciences, Inc.、Intercure Ltd.涨幅较大,大自然药业、Cbdmd, Inc.、Biofrontera Inc.较为活跃,换手率分别为15.36%、6.03%、4.01%,振幅较大的相关个股有Intra-Cellular Therapies Inc.、Kamada Ltd.、Citius Oncology, Inc.,振幅分别为14.38%、12.24%、10.49%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230538a21d168d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230538a21d168d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"gpt_icon":0},{"id":"2500086429","title":"Organogenesis Holdings Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500086429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500086429?lang=zh_cn&edition=full","pubTime":"2025-01-03 02:33","pubTimestamp":1735842818,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日02时33分,Organogenesis Holdings Inc.股票出现异动,股价快速下跌5.00%。截至发稿,该股报3.04美元/股,成交量21.9627万股,换手率0.17%,振幅7.34%。Organogenesis Holdings Inc.股票所在的制药行业中,整体涨幅为0.19%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。其部分产品包括 PuraPly Antimicrobial、Affinity、NuShield、Apligraf、Dermagraft 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103023338a2133665&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103023338a2133665&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"gpt_icon":0},{"id":"2494339203","title":"Organogenesis Holdings Inc.盘中异动 大幅下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494339203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494339203?lang=zh_cn&edition=full","pubTime":"2024-12-28 01:19","pubTimestamp":1735319987,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日01时19分,Organogenesis Holdings Inc.股票出现波动,股价大幅下挫5.03%。截至发稿,该股报3.12美元/股,成交量16.4313万股,换手率0.13%,振幅7.62%。Organogenesis Holdings Inc.股票所在的制药行业中,整体跌幅为0.92%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228011947a20c2015&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228011947a20c2015&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"gpt_icon":0},{"id":"2493793870","title":"Organogenesis Holdings Inc.盘中异动 股价大涨5.08%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493793870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493793870?lang=zh_cn&edition=full","pubTime":"2024-12-24 01:11","pubTimestamp":1734973913,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日01时11分,Organogenesis Holdings Inc.股票出现异动,股价快速上涨5.08%。截至发稿,该股报3.21美元/股,成交量12.9512万股,换手率0.10%,振幅5.74%。Organogenesis Holdings Inc.股票所在的制药行业中,整体涨幅为1.69%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224011153984d3dac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224011153984d3dac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"gpt_icon":0},{"id":"2492155897","title":"Organogenesis Holdings Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492155897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492155897?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:59","pubTimestamp":1734551962,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时59分,Organogenesis Holdings Inc.股票出现异动,股价大幅跳水5.04%。截至发稿,该股报3.39美元/股,成交量29.6578万股,换手率0.22%,振幅5.85%。Organogenesis Holdings Inc.股票所在的制药行业中,整体跌幅为1.40%。Organogenesis Holdings Inc.公司简介:Organogenesis Holdings Inc 是一家再生医学公司,专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035927984cb7a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035927984cb7a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.organogenesis.com","stockEarnings":[{"period":"1week","weight":-0.1955},{"period":"1month","weight":-0.1748},{"period":"3month","weight":-0.3803},{"period":"6month","weight":-0.3767},{"period":"1year","weight":0.0456},{"period":"ytd","weight":-0.3803}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Organogenesis Holdings Inc.是特拉华州的一家公司。该公司是一家领先的再生医学公司,在先进的伤口护理和外科生物制剂(包括骨科和脊柱)中提供生物活性和非细胞生物材料产品组合。Organogenesis全面的产品组合旨在治疗各种有修复和再生需求的患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.030316},{"month":2,"riseRate":0.4,"avgChangeRate":0.031483},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.059755},{"month":4,"riseRate":0.333333,"avgChangeRate":0.008569},{"month":5,"riseRate":0.444444,"avgChangeRate":0.027529},{"month":6,"riseRate":0.444444,"avgChangeRate":0.014138},{"month":7,"riseRate":0.666667,"avgChangeRate":0.038466},{"month":8,"riseRate":0.555556,"avgChangeRate":-0.058414},{"month":9,"riseRate":0.444444,"avgChangeRate":0.019558},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.057674},{"month":11,"riseRate":0.5,"avgChangeRate":0.080332},{"month":12,"riseRate":0.25,"avgChangeRate":0.091349}],"exchange":"NASDAQ","name":"Organogenesis Holdings Inc","nameEN":"Organogenesis Holdings Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Organogenesis Holdings Inc(ORGO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Organogenesis Holdings Inc(ORGO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Organogenesis Holdings Inc,ORGO,Organogenesis Holdings Inc股票,Organogenesis Holdings Inc股票老虎,Organogenesis Holdings Inc股票老虎国际,Organogenesis Holdings Inc行情,Organogenesis Holdings Inc股票行情,Organogenesis Holdings Inc股价,Organogenesis Holdings Inc股市,Organogenesis Holdings Inc股票价格,Organogenesis Holdings Inc股票交易,Organogenesis Holdings Inc股票购买,Organogenesis Holdings Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Organogenesis Holdings Inc(ORGO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Organogenesis Holdings Inc(ORGO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}